Literature DB >> 36044476

Characterisation of a soil MINPP phytase with remarkable long-term stability and activity from Acinetobacter sp.

Gregory D Rix1, Colleen Sprigg1, Hayley Whitfield1, Andrew M Hemmings1,2, Jonathan D Todd1, Charles A Brearley1.   

Abstract

Phylogenetic analysis, homology modelling and biochemical methods have been employed to characterize a phytase from a Gram-negative soil bacterium. Acinetobacter sp. AC1-2 phytase belongs to clade 2 of the histidine (acid) phytases, to the Multiple Inositol Polyphosphate Phosphatase (MINPP) subclass. The enzyme was extraordinarily stable in solution both at room temperature and 4°C, retaining near 100% activity over 755 days. It showed a broad pH activity profile from 2-8.5 with maxima at 3, 4.5-5 and 6. The enzyme showed Michaelis-Menten kinetics and substrate inhibition (Vmax, Km, and Ki, 228 U/mg, 0.65 mM and 2.23 mM, respectively). Homology modelling using the crystal structure of a homologous MINPP from a human gut commensal bacterium indicated the presence of a potentially stabilising polypeptide loop (a U-loop) straddling the active site. By employ of the enantiospecificity of Arabidopsis inositol tris/tetrakisphosphate kinase 1 for inositol pentakisphosphates, we show AC1-2 MINPP to possess D6-phytase activity, which allowed modelling of active site specificity pockets for InsP6 substrate. While phytase gene transcription was unaltered in rich media, it was repressed in minimal media with phytic acid and orthophosphate as phosphate sources. The results of this study reveal AC1-2 MINPP to possess desirable attributes relevant to biotechnological use.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36044476      PMCID: PMC9432691          DOI: 10.1371/journal.pone.0272015

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

Since the 1990’s when the first commercial phytase Natuphos® was released to market [1], the market for industrial enzymes has grown to an estimated value of 4.5–5 billion USD (in 2015), of which food and feed applications account for 55–60% [2]. The advent and development of phytases for use in industry is regarded as one of the top ten landmark discoveries in swine nutrition [3]. Alongside benefits to animal nutrition, commercial phytases have also been touted for their environmental benefits, namely the amelioration of phosphate pollution to waterways [4,5]. Phytases in bacteria, fungi, plants and animals [6,7] are commonly classified by protein fold and catalytic mechanism. Four canonical phytases are commonly considered, the β-propeller phytases (BPPhy), Purple Acid Phytases (PAPhy), Protein Tyrosine Phosphatase-like Phytase (PTPLPs) (Cysteine phytases) and Histidine Acid Phytases (HAPhys) [8], but the classification has been extended by the characterization of soil metagenomes to include metallo-β-lactamase enzymes [9,10]. The histidine acid phytases are also comprised of a subclass, the Multiple Inositol Polyphosphate Phosphatases (MINPPs), which deviate from HAPhy sequence homology [11]. Although these enzymes were previously considered to function only in animals [12], the first crystallographic study was that of the enzyme from the human gut commensal Bacteroides thetaiotaomicron, where the possibility of horizontal gene transfer was mooted [13]. Phytases act through the sequential dephosphorylation of phytate, with different enzymes initiating attack on different positions on the phytate molecule [14]. Many bacterial and fungal phytases are D3-phytases (EC 3.1.3.8), whilst plants as well as Escherichia coli possess enzymes commonly called 6-phytases (EC 3.1.3.26). It should be noted however that phytases from plants first described as 1D4-phytases [15] from which the EC 3.1.3.26 designation arises are commonly conflated with 6-phytases (1D6 = 1L4). Enzymes that attack the 5-position have also been identified, including a PTPLP phytase from Selenomonas ruminantium [16,17] as well as a lily pollen histidine acid phosphatase of MINPP class [16-19]. The search for more effective phytases with desirable characteristics, improved catalytic activity, heat stability, a wide pH activity profile, enhanced acid- and protease-resistance and cost-effective production has gathered apace [20]. The characterisation of a more effective bacterial phytase from E. coli shifted development from fungal sources to bacteria [21], leading to a new generation of enzymes considered superior in several desirable ways such as activity, affinity, proteolytic resistance [5,22]. This search has also been extended into soil environments where myo-, neo-, scyllo- and D-chiro forms of inositol phosphates represent substantial reserves of organic phosphate, albeit adsorbed and mostly inaccessible [23]. The soil environment is important for both culture-dependent and culture-independent studies due to the vast diversity of microflora and still untapped potential of soil microbes [24]. These environments have been the target for both metagenomic studies [25,26], as well as culture-dependent phytase isolation studies [27,28]. With phytases from contrasting environments discovered and isolated [29-31], their individual differences can be analysed and used to aid the development and design of more active, thermostable phytases [32,33]. This manuscript details the characterisation of one of the first recombinant MINPP to be isolated from soil Acinetobacter sp., that as an exemplar of non-commensal MINPPs has facets of character that illustrate the potential for development of feed enzymes from this sub-class of phytase and for isolation of similar enzymes from soil. The phylogenetic relationship of Acinetobacter MINPP phytase to other phytases is shown in Supporting information.

Materials and methods

Media

Lysogeny broth was made using sodium chloride, agar (Merck Life Science), tryptone and yeast (Formedium, UK). Na-InsP6 stocks (provided by AB Vista) were prepared in dH2O and adjusted to pH 7 with HCl. Phytic acid sodium salt hydrate (Sigma P8810) was used for the qPCR studies and similarly prepared in dH2O and buffered to pH 7.

Construction of phylogeny

The phylogeny tree was created using 21 Histidine Acid Phytases (HAPhy), 27 Multiple Inositol Polyphosphate Phosphatases (MINPP), 17 Beta-propeller phytases, 10 Protein Tyrosine Phosphatase-like Phytases and 22 Purple Acid Phytases. The sequences were chosen to produce a diverse tree both internally and between genes. These were aligned using the online resource MAFFT Version 7 [34] using their automated strategy which choses between, FFT-NS-1, FFT-NS-2, FFT-NS-I or L-INS-I, one of 4 progressive or iterative refinement methods. The Newick output from the alignment was uploaded to the Interactive Tree of Life (iTOL) [35].

Phytase isolation

Acinetobacter sp. AC1-2 was isolated from untilled agricultural soil from Fakenham, UK, purified to single colonies and identified by sequencing of its 16S rRNA gene (GenBank MT450216) and genome (GenBank JABFFO000000000) as described in Rix et al [36]. Phytase activity was followed by HPLC [36]. Chromatography data were exported as x,y data and redrawn in GraphPad Prism v.6.0 (GraphPad Software, USA).

Phytase production and purification

The Acinetobacter sp. phytase gene (ac1-2 MINPP) was identified in the bacterial genome (GenBank JABFFO000000000), with a theoretical protein mass 58.57 kDa, nucleotide and amino acid sequences are presented in the Supporting information. Genomic DNA was extracted as described in the Supporting information. Primers were designed for Gateway cloning in accordance with the Gateway™ Cloning Technology from Life Technologies manual. A two-stage PCR (LR and BP reaction) using the high-fidelity polymerase, Phusion® (NEB), was performed to clone the full gene with the adapters necessary for gateway cloning first into the donor vector pDONR207, followed by cloning into the destination vector pDEST17 (Supporting information). The ac1-2 MINPP pDEST17 construct was transformed into Rosetta 2 pLysS (Novagen) for protein expression studies. The protein purification method is provided in detail in the Supporting information. Briefly, ac1-2 MINPP expression was induced in Rosetta 2 pLysS cells. Initial purification efforts expressed a low purity, low activity product. Thereafter the signal peptide was identified using Signal P 5.0 [37], and a new set of primers designed to remove the signal peptide. The protein expressed, hereafter called AC1-2 MINPP was purified using a 1 mL Histrap™ HP column followed by a HilLoad 16/600 Superdex 75 PG column on an ÄKTA pure protein purification system. The purified protein was visualised using SDS-page gel electrophoresis. The protein was sequenced by Protein Mass Fingerprinting using MALDI at the John Innes Centre, Norwich, UK, and compared with the Acinetobacter sp. genome to confirm expression.

Structural biology

Homology modelling of the structure of AC1-2 MINPP was carried out using SWISS-MODEL [38]. Two models of the enzyme less its signal peptide as predicted by SignalP 5.0 [37] were produced based on X-ray crystal structures of the highest scoring sequence homologue, the MINPP from Bifidobacterium longum (BlMINPP) with which AC1-2 MINPP shares 34% sequence identity. A first model was based on the structure of apo-BlMINPP (PDB entry 6RXD) [11] and the other on the structure of the enzyme complexed with the non-hydrolysable substrate analogue inhibitor, D-myo-inositol hexakissulfate (InsS6) (PDB entry 6RXE). The GMQE scores of the two models were 0.60 and 0.61, respectively. Note that PDB 6RXE shows InsS6 to exhibit static disorder in its complex with BlMINPP. Two conformations of the inhibitor are observed placing the 4- and 6-sulfates in the catalytic A specificity pocket (for an explanation of specificity pocket nomenclature see [11]). Despite this disorder, the sulfate groups in all specificity pockets except D and E are essentially superimposable in the two binding poses. The coordinates of InsS6 were therefore transferred from PDB 6RXE directly to the homology model of AC1-2 and the sulfate groups substituted with phosphates to generate a model for the AC1-2 complex with phytate. Residues forming the specificity pockets of AC1-2 MINPP were inferred from the predicted structure of its complex with InsS6 and compared with that of Bifidobacterium longum (PDB 6RXE), Bacteroides thetaiotaomicron (BtMINPP) (sequence identity 21%; PDB 4FDU) [13], and the extracellular histidine phytase from Aspergillus fumigatus (sequence identity 15%; PDB 1SK8) [39].

Phytase assays

Phytase specific activity was determined using the molybdenum blue method for phosphate release [40,41]. One phytase unit is defined as the amount of the enzyme releasing 1 μM inorganic phosphate per minute under the assay conditions. All samples were assayed in triplicate [42]. These reactions were performed from a working stock of AC1-2 MINPP in 25% w/v trehalose unless stated otherwise. In brief, 2.5 μL of 250 nM AC1-2 MINPP was added to 42.5 μL of 0.2 M Na-Acetate pH 5 buffer. The enzyme-buffer solution was mixed with 5 μL of 50 mM InsP6 on ice before being heated at 37°C for 15 minutes in a PCR machine. Triplicate reactions were performed. The reaction was stopped by addition of 50 μL of a 4:1 ratio of ammonium molybdate sulphuric acid solution, prepared by mixing solutions of molybdate (6 g NH4Mo7O24.4H2O and 22 mL 98% H2SO4 in 400 mL) with ferrous sulphate solution (2.16 g iron (II) sulphate heptahydrate, 2 drops 98% H2SO4 in 5mL). Absorbance was measured at 700 nm after 15 minutes and compared against a calibration with NaH2PO4. AC1-2 MINPP was used at a final concentration of 12.5 nM unless stated otherwise.

Time-course

For analysis of the inositol phosphate products of AC1-2 MINPP action on InsP6, assays were performed in 0.2 M Na-Acetate pH 5.

Determination of enantiomerism of principal InsP5 product

The D-and/or L-Ins(1,2,3,4,5)P5 [InsP5 6/4-OH] product of AC1-2 MINPP action on InsP6 was collected from phytase assays containing 5mM InsP6 substrate in 20 mM Na-Acetate pH 5 buffer incubated for 2h at 31°C and containing 45–90 nM of glycerol/BSA-stabilized enzyme (0.5 mg/mL BSA, 25% w/v glycerol). The reaction products were resolved by HPLC on a CarboPac PA200 column eluted with HCl [43], but without addition of post-column ferric nitrate. Fractions (1.5 min, 0.6 mL) containing peak(s) were transferred to borosilicate glass tubes, frozen on dry-ice and freeze-dried to remove HCl. The dried samples were rehydrated with 0.5 mL 18.2 Mohm.cm water, aliquots (5 μL) were retained for HPLC, and samples were frozen and freeze-dried again, before rehydration with 50 μL water. An estimated 40 nmol of D-and/or L-Ins(1,2,3,4,5)P5 [InsP5 6/4-OH] was recovered in a fraction devoid of other inositol phosphates. The recovered, HPLC-confirmed D-and/or L-Ins(1,2,3,4,5)P5 fraction was presented as substrate to AtITPK1, which we have shown is capable of pyrophosphorylating both InsP6 and D-Ins(1,2,3,4,5)P5 [InsP5 6-OH] but not D-Ins(1,2,3,5,6)P5 [InsP5 4-OH] [43]. Briefly, assays of 20 μL volume containing 20mM Hepes, pH 6.5, 1 mM MgCl2, 2 mM ATP, 5 mM phosphocreatine and 3U creatine kinase were supplemented with 5 μM ITPK1 and 0.5 mM substrate. The substrates used were: D-Ins(1,2,3,4,5)P5 as decasodium salt (SiChem GmbH) as a positive control, D-Ins(1,2,3,5,6)P5 as decasodium salt (Sichem GmbH) as a negative control, InsP6, purified from rice bran [44] as positive control and HPLC-purified InsP5 fraction as unknown. Reactions were incubated for 12 h at 25°C, stopped by addition of an equal volume of 60 mM (NH4)2HPO4, pH 3.5 with orthophosphoric acid, and the whole made up to 70 μL with water. Aliquots (50 μL) were analysed by HPLC on CarboPac PA200 eluted with HCl and subsequent post-column addition of ferric nitrate for detection of inositol phosphates [43]. D-Ins(1,3,4,5)P4 and D-Ins(1,4,5,6)P4, used in other HPLC runs, were obtained from Cayman Chemical, USA, while Ins(1,3,4,6)P4 was obtained from Professor Barry Potter, University of Oxford [43].

pH profile

The pH profile of AC1-2 MINPP was measured in 0.2M buffer: glycine HCl, pH 2–3.5; sodium acetate, pH 4–5.5; Bis-Tris, pH 6–7; Tris HCl, pH 8–8.5.

Enzyme activity towards other substrates

Assays were performed as described for phytate with a range of phosphate monoesters.

Inhibition

The effect of metal ions on enzyme activity was investigated with or without the addition of 1 mM K+, Mn+, Cu2+, Co2+, Mg2+, Ca2+, Zn2+, Fe2+/3+ or IS6, the substrate analogue of InsP6, directly to the reaction mixture.

Thermostability

The short-term thermostability of AC1-2 MINPP was measured by firstly incubating the enzyme-buffer mixture at 4, 37, 50, 60 and 70°C for 10 minutes. Following this, activity assays were performed as described above at 37°C.

Long-term stability in different storage buffers

The stability of AC1-2 MINPP was measured over an extended period. The protein in gel filtration buffer was mixed in 1:1 ratio with different stabilising agents, 50% (w/v) trehalose, 50% (w/v) trehalose and 1 mg/mL BSA, 50% (w/v) sucrose, 50% (w/v) sucrose and 1 mg/mL BSA, 50% (w/v) glycerol, 50% (w/v) glycerol and 1 mg/mL BSA, 1 mg/mL BSA, or gel filtration buffer, and left at room temperature. The storage protein concentration was 4 μM. On occasions thereafter, aliquots were tested for activity at a final protein concentration of 50 nM.

Kinetic characterization

AC1-2 MINPP was assayed at twelve substrate concentrations from 12.5–3750 μM InsP6. The progress of reaction curve was fitted to a non-linear regression model for substrate inhibition using GraphPad Prism 8.0.1.

Measurement of inorganic phosphate content of InsP6 used in gene expression study

The concentration of inorganic phosphate in a 1 mM InsP6 solution (Sigma P8810) was determined, by suppressed ion conductivity HPLC [45], to be 0.365 mM and this concentration of inorganic phosphate was included as a control in the experiments described in Fig 9.

RNA extraction and quantification

A 10 mL culture of Acinetobacter sp. cells growing in either LB or Minimal Media, supplemented or not with 1mM InsP6 or inorganic phosphate (0.365 mM), equivalent to that impurity in the InsP6, was extracted after reaching late exponential phase. Cells were centrifuged at 6000 x RPM for 5 minutes and to the pellet 1 mL of TRIzol/TRI reagent (Invitrogen) was added. Tubes were vortexed and incubated at room temperature for 5 minutes. Chloroform (0.2mL) was added, the tubes vortexed, incubated at room temperature for 2 minutes and centrifuged at 13,000 x RPM for 10 minutes at 4°C. Isopropanol (500 μL) was added to the (removed) upper aqueous phase, mixed by inversion and incubated for 10 minutes at room temperature to precipitate RNA. Pelleted (12,000 x RPM, 10 minutes, 4°C) RNA was washed with 1 mL of 75% ethanol, centrifuged, air-dried, and resuspended in 30 μL RNase-free water.

DNase treatment

Briefly, 1 μg of RNA, 1 μL DNase (Promega RQ1 RNase-free DNase), 1 μL 10X Reaction buffer were made up to 10 μL with RNAase-free water (NEB) and incubated at 37°C for 30 minutes, before addition of 1 μL of RQ1 stop solution and further incubation at 65°C for 10 minutes.

cDNA synthesis

cDNA synthesis was performed according to the First Strand cDNA Synthesis Standard Protocol from New England BioLabs (NEB) using ProtoScript II Reverse Transcriptase. Briefly: to 1 μg of DNase-treated RNA, 2 μL Random Hexamers (NEB Random Primer Mix) and 1 μL dNTP mix (10 mM New England Biolabs) was added to a total volume of 10 μL. These were heated at 65°C for 5 minutes before addition of 4 μL 5X Protoscript II Buffer (NEB), 2 μL 0.1 M DTT, 1 μL Protoscript II Reverse Transcriptase (NEB) and 3 μL RNase-free H2O, to a total volume of 20 μL. Following sequential incubation at 25°C for 5 minutes and 42°C for 60 minutes, enzyme was inactivated by heating at 65°C for 20 minutes. The concentration of cDNA was measured on a NanoDrop (Thermo Scientific) and diluted to a concentration of 250 ng/μL.

qPCR primer design

qPCR primer sets were designed using the Primer Express Software 3.0.1 with the ac1-2 MINPP gene followed by Primer Blast against the Acinetobacter sp. genome to discount secondary product formation. The primers used and the conditions of their use are detailed in Supporting information.

Quantitative PCR

qPCRs were performed for all individual samples in biological and technical triplicates in 20 μL reaction volume, using SensiFast SYBR Hi-Rox Kit (Bioline), with 400 nM primer on a StepOne Plus Real-Time PCR System (Applied Biosystems). The ‘housekeeping’ gene RecA was analysed as reference.

Data analysis

Statistical analyses were performed using GraphPad Prism 8.0.1. The ΔCt values were first investigated for outliers using the ROUT method, with any outliers being removed from the dataset. The dataset was then analysed for normality and lognormality using the Anderson-Darling test indicating the normalised distribution of the datasets. Significance between the two datasets were analysed using either an unpaired, parametric T-test, or an unpaired nonparametric Mann-Whitney test.

Results

Specificity of attack on phytate by Acinetobacter sp. AC1-2 phytase

Confirmation that Acinetobacter sp. AC1-2 encodes a MINPP, likely responsible for the ability of the isolate to degrade phytate in solid media and liquid culture was reported [36]. Here we analyse the products of phytate degradation by recombinant AC1-2 MINPP. Fig 1 shows sequential degradation of phytate over a period of 8h with 12.5 nM protein assayed at pH 5. At early stages of degradation three peaks of InsP5 were detected with a predominance of D/L-Ins(1,2,3,4,5)P5 and near equal amounts of D/L-Ins(1,2,4,5,6)P5 and Ins(1,2,3,4,6)P5. The absence of Ins(1,3,4,5,6)P5 among products suggests that the enzyme does not attack the single axial-orientated phosphate on the 2-position. The generation of multiple InsP5s is typical of the commensal bacterial MINPPs characterized to date [11,13,46,47].
Fig 1

Degradation of phytate by AC1-2 MINPP.

Degradation was followed by HPLC at 30 min, 2h, 4h and 8h. Structures of inositol phosphate products (as pairs of enantiomers where appropriate, named by D-notation) are shown.

Degradation of phytate by AC1-2 MINPP.

Degradation was followed by HPLC at 30 min, 2h, 4h and 8h. Structures of inositol phosphate products (as pairs of enantiomers where appropriate, named by D-notation) are shown. Explicit testing of the lack of loss of the 2-phosphate during dephosphorylation has been shown for the related commensal enzyme BtMINPP [13]. Here, we show for AC1-2 MINPP that the InsP4 products of dephosphorylation of InsP6 do not co-elute with Ins(1,3,4,5)P4 or Ins(1,4,5,6)P4, or their enantiomers which are unresolvable (Supporting information). One of the InsP4 products co-eluted with Ins(1,3,4,6)P4 which is a meso-compound (Supporting information) but as this compound co-elutes with Ins(1,2,3,4)P4 and its enantiomer Ins(1,2,3,6)P4 (Supporting information) we cannot assign identity unequivocally. Of the fifteen stereoisomers of InsP4, only Ins(1,3,4,5)P4, Ins(1,4,5,6)P4, or their enantiomers, and Ins(1,3,4,6)P4 possess a 2-phosphate. Nevertheless, the absence of detectable Ins(1,3,4,5,6)P5 in more than thirty independent AC1-2 MINPP assays with different degrees of dephosphorylation leads us to conclude that AC1-2 MINPP lacks InsP6 2-phosphohydrolase (phytase) activity. The co-production of InsP4 with InsP5 at 30 min, before the peak of accumulation of InsP5, suggests that, even in the presence of excess InsP6, InsP5s are better substrates than InsP6. Multiple peaks of InsP4 co-exist in the degradation products with InsP5 and InsP3 products, until the InsP5s are wholly consumed at which point a single peak of D/L-Ins(1,2,4,6)P4 was observed. InsP4s are particularly well resolved on the CarboPac PA200 column [44] allowing identification of the major and minor routes of initial and subsequent dephosphorylations. InsP3, of which there are 20 possible stereoisomers, is less well resolved on this column, but it is evident that as InsP4 degradation proceeds to exhaustion–one of the two resolvable peaks (which could contain multiple isomers) predominates, concurrent with the appearance of a single peak of InsP2. While there are fifteen possible stereoisomers of InsP2, we may reasonably assume that the peak is comprised of species retaining the 2-phosphate. Similarly, we may assume that the monophosphate product is Ins2P, which along with other monophosphates co-elutes with Pi at the solvent front of this HPLC system–accounting for the progressive accumulation of Pi over the course of the assay. The lack of HPLC matrices for separation of inositol phosphate enantiomers precludes us from simple chromatographic determination of the ability, or otherwise, of the enzyme to discriminate between enantiotopic D4- and D6-positions or D1- and D3-positions. We, therefore, sought alternative approach to the problem.

Application of a stereospecific pyrophosphorylating enzyme activity to identification of InsP5 products of AC1-2 MINPP action

We have shown that AtITPK1 pyrophosphorylates InsP6 and D-Ins(1,2,3,4,5)P5 [InsP5 6-OH] exclusively among InsP5s [43]. We exploited this activity for the characterization of this member of the MINPP class. The D-and/or L-Ins(1,2,3,4,5)P5 [InsP5 6/4-OH] product of AC1-2 MINPP action on InsP6 was purified by HPLC, desalted and the recovered fraction shown to be devoid of other inositol phosphates (Supporting information). The pyrophosphorylating activity of ITPK1 was tested with InsP6, D-Ins(1,2,3,4,5)P5 [InsP5 6-OH] and D-Ins(1,2,3,5,6)P5 [InsP5 4-OH], beside the recovered InsP5 fraction. InsP6 was converted in 90% yield to 5-InsP7 (5PP-InsP5, see [43]] (Fig 2C and 2D), D-Ins(1,2,3,4,5)P5 was converted to pyrophosphate product (PP-InsP4) in 58% yield (Fig 2G and 2H), InsP6 is a better substrate, while D-Ins(1,2,3,5,6)P5 was not modified by ITPK1 (Fig 2E and 2F). The recovered InsP5 fraction was converted in approximately 12% yield to a pyrophosphate product (a PP-InsP4) that eluted (on CarboPac PA200) mid-way between Ins(1,3,4,5,6)P5 [InsP5 2-OH], the last-eluting InsP5, and InsP6 with identical retention time to the PP-InsP4 generated from D-Ins(1,2,3,4,5)P5 (Fig 2A and 2B) (after [43]). These experiments confirm that AC1-MINPP has D6-phytase activity and rationalize modelling of InsP6 substrate interaction with AC1-MINPP (see below). The lack of pyrophosphorylating enzymes with enantiomeric preference for D-Ins(1,2,3,5,6)P5 (over D-Ins(1,2,3,4,5)P5) precludes an equivalent approach that could unequivocally identify D4-phytase activity for AC1-2 MINPP, though we cannot discount it.
Fig 2

Schematic detailing potential pathways of degradation of phytate by AC1-2 MINPP.

Predominant products are indicated by size of font; * indicates the predominant InsP5 impurity in the substrate; weight of arrow indicates likelihood of route of degradation.

Schematic detailing potential pathways of degradation of phytate by AC1-2 MINPP.

Predominant products are indicated by size of font; * indicates the predominant InsP5 impurity in the substrate; weight of arrow indicates likelihood of route of degradation. Structures of BlMINPP-IS6 complexes (PDB 6XRE [11]) show static disorder with ligand bound in two orientations in different monomers of the crystallographic asymmetric unit. The similar occupancy ratios of ligands placing the sulfate equivalent of 1D-4 phosphate and 1D-6 phosphate (of InsP6) close to the catalytic histidine in the different units may indicate that the enzyme has little discrimination between attack on the 1D4- and 1D6-positions [11]. Considering these observations, the major and minor routes of the first two dephosphorylations catalysed by AC1-2 MINPP are summarized in Fig 2.

Structural features of AC1-2 MINPP: Homology modelling predicts a polypeptide insert in AC1-2 MINPP that spans the active site

The closest sequence homologue to AC1-2 MINPP for which a high-resolution structure exists in the PDB was found to be the MINPP from Bifidobacterium longum, BlMINPP, (Supporting information), the proteins share 34% sequence identity. Homology modelling was used to generate models for the structure of AC1-2 MINPP in the apo-state and as bound to InsS6. The overall structure of AC1-2 MINPP is therefore predicted to resemble BlMINPP having α/β- and α-domains with an active site arranged between the two domains. Phylogenetic analysis has revealed three groups of polypeptide inserts in MINPP sequences named U-loops [11] which have been given the identifiers A, B, or C depending on insert length. Possessing a lipoprotein-like SEC/SPII signal peptide, AC1-2 MINPP has a 41-residue polypeptide insertion in the α-domain that maps to the type A-type U-loop found in the MINPP from Bifidobacterium longum (BlMINPP) (Fig 3A). The insertion is followed immediately by a characteristic tetrapeptide motif (DAAM in BlMINPP and DAAA in AC1-2 MINPP), which is absent in sequences that do not contain a U-loop. The AC1-2 MINPP insertion is, however, shorter than the type A-type U-loop in BlMINPP by eight residues and lacks cysteine residues that form a disulphide bridge in the latter. The U-loop residues in BlMINPP span the active site and close down onto a modelled bound InsS6 substrate analogue (and by inference onto a bound substrate molecule) through a rigid body motion involving a major part of the α-domain [11]. The prediction of a large type A U-loop in AC1-2 MINPP strongly suggests the presence of similar rigid body domain motions, presumably to allow the imposition of additional contacts with phytate in the complex, particularly in specificity pocket D (Fig 3B). However, it is relevant to note that the nature of the homology modelling process, particularly with respect to the prediction of the conformation of large polypeptide loops, leaves room for considerable uncertainty in the conformation of the U-loop in AC1-2.
Fig 3

Predicted structural features of AC1-2 MINPP: U-loop and specificity pockets.

A, Alignment of the amino acid sequences of AC1-2 MINPP and BlMINPP in the region of the U-loop. A blue box delimits U-loop residues. Cysteine residues forming a disulphide bridge in the crystal structure of BlMINPP (PDB 6XRE) are highlighted yellow. Conserved residues (in red) are part of a MINPP-specific tetrapeptide motif. Positions of residues contributing to specificity pockets are indicated by inverted blue triangles. B, Molecular surface representations of the structures of apo- (left) and InsS6-bound (right) AC1-2 MINPP predicted by homology modelling. The U-loop residues are coloured green with the remainder of the molecule in cyan. Atoms of the substrate analogue inhibitor, InsS6, are shown as spheres and coloured red (oxygen), cyan (carbon) and orange (sulphur). C, Residues predicted to contribute to the specificity pockets of AC1-2 MINPP and selected histidine phytases. AC1-2, Bl and Bt are the MINPPs from Acinetobacter sp. AC1-2 (this study), Bifidobacterium longum (PDB 6XRE) and Bacteroides thetaiotaomicron (PDB 4FDU), respectively. Af is the histidine phytase from Aspergillus fumigatus (PDB 1SK8). Specificity pockets are labelled A-F as described by Acquistapace et al. (2000). Each alignment shows spatially equivalent residues in the specificity pockets of each enzyme, which lie within 5Å of the phosphorus of the corresponding phosphate group on the substrate (the positions of sulphate groups of the inhibitors in each structure are taken to be the same as the phosphate groups of phytate. Numbering is according to the AC1-2 sequence. Residues that are completely conserved are highlighted in bold with red text. Red arrows indicate residues that have the closest interactions with the substrate analogue inhibitor. Note that residues 298 and 301 contributing to the D-pocket are found on the U-loop. Residues marked with an asterisk in pockets D and E are predicted to not interact with the substrate when bound with the 4-phosphate in the A-pocket.

Predicted structural features of AC1-2 MINPP: U-loop and specificity pockets.

A, Alignment of the amino acid sequences of AC1-2 MINPP and BlMINPP in the region of the U-loop. A blue box delimits U-loop residues. Cysteine residues forming a disulphide bridge in the crystal structure of BlMINPP (PDB 6XRE) are highlighted yellow. Conserved residues (in red) are part of a MINPP-specific tetrapeptide motif. Positions of residues contributing to specificity pockets are indicated by inverted blue triangles. B, Molecular surface representations of the structures of apo- (left) and InsS6-bound (right) AC1-2 MINPP predicted by homology modelling. The U-loop residues are coloured green with the remainder of the molecule in cyan. Atoms of the substrate analogue inhibitor, InsS6, are shown as spheres and coloured red (oxygen), cyan (carbon) and orange (sulphur). C, Residues predicted to contribute to the specificity pockets of AC1-2 MINPP and selected histidine phytases. AC1-2, Bl and Bt are the MINPPs from Acinetobacter sp. AC1-2 (this study), Bifidobacterium longum (PDB 6XRE) and Bacteroides thetaiotaomicron (PDB 4FDU), respectively. Af is the histidine phytase from Aspergillus fumigatus (PDB 1SK8). Specificity pockets are labelled A-F as described by Acquistapace et al. (2000). Each alignment shows spatially equivalent residues in the specificity pockets of each enzyme, which lie within 5Å of the phosphorus of the corresponding phosphate group on the substrate (the positions of sulphate groups of the inhibitors in each structure are taken to be the same as the phosphate groups of phytate. Numbering is according to the AC1-2 sequence. Residues that are completely conserved are highlighted in bold with red text. Red arrows indicate residues that have the closest interactions with the substrate analogue inhibitor. Note that residues 298 and 301 contributing to the D-pocket are found on the U-loop. Residues marked with an asterisk in pockets D and E are predicted to not interact with the substrate when bound with the 4-phosphate in the A-pocket.

Specificity pocket content provides insights to the residue determinants of AC1-2 MINPP positional specificity

Phytases can be grouped according to the specific position of the phosphate ester group on the phytate molecule at which hydrolysis first occurs. Accordingly, phytases which are principally involved in phytate mineralization show high stereospecificity and can be described as 3-phytases (EC 3.1.3.8) or 6-phytases (EC 3.1.3.26). MINPPs, on the other hand, show lower stereospecificity and hydrolyze phytate to generate a mixture of inositol pentakisphosphates. AC1-2 behaves as a typical MINPP and displays 6-phytase activity (Fig 2). We employed homology modelling and structural alignment in an effort to investigate the residue determinants of AC1-2 MINPP positional specificity, employing the specificity pocket nomenclature adopted by Acquistapace et al [11] in study of the cell-surface anchored MINPP from Bifidobacterium longum [11). Alignment of the structures of sequence homologues to that of AC1-2 MINPP revealed residues forming the specificity pockets in related clade 2 histidine phytases [48] (Fig 3A). The enzymes chosen for analysis were homologues to AC1-2 MINPP for which high-resolution crystal structures of their complexes with InsS6 were available. These include the MINPPs from Bifidobacterium longum, a predominant 4/6-phytase [11], and Bacteroides thetaiotaomicron, a predominant 5-phytase [13]. We also included the stereospecific histidine phytase from Aspergillus fumigatus [39]. This D3-phytase (EC: 3.1.3.8) is structurally more similar to MINPPs, as a class, than is the E. coli D6-phytase [11]. Consideration of the spatially conserved residues in the different specificity pockets gives possible insights into the molecular basis for the D6-phytase activity of AC1-2 MINPP. Note that myo-inositol hexakissulfate (InsS6) is reported to act as a competitive inhibitor of phytases and in crystal structures is assumed to mimic the substrate by adopting a pseudo-productive binding [11,13,49,50]. In the following discussion, the positions of the sulfate groups of InsS6 were therefore taken to represent the phosphate groups of phytate as bound to the enzymes. The results of the following analysis must therefore be taken as indicative. The scissile phosphate group of the substrate occupies pocket A (Fig 3C). The phosphate here is intimately bound, making six polar contacts with pocket residues. The role of the pocket is to engage with the scissile phosphate and to position and orient it for hydrolysis, consequently, pocket A residues are highly conserved between the enzymes considered. Residues in pockets B, C and F have fewer contacts with their corresponding phosphate groups but those residues involved in direct polar contacts with the substrate analogue (and therefore by inference with the substrate), while predominantly conserved with BlMINPP, vary in the B.thetaiotaomicron and A.fumigatus enzymes. Given the observed D6-phytase positional specificity of AC1-2 MINPP (Fig 2), interactions at residues 18, 199 and 352 (AC1-2 numbering) can therefore be identified as candidates for residue determinants of positional specificity in this subset of enzymes. Indeed, the mutation R183D in BtMINPP (equivalent to residue 199 in AC1-2 MINPP) converts BtMINPP, a predominant 5-phytase, to an A.fumigatus- or Klebsiella-like D1/3-phytase, we use the term ‘D1/3-‘ to indicate the unknown enantiospecificity of BtMINPP, in contrast to the known D3-specificity of the Aspergillus and Klebsiella enzymes [39,51].

Biochemical properties of AC1-2 MINPP

Initial purification efforts yielded an impure protein with low specific activity (13 U/mg). Therefore, purification was repeated after expression from a construct lacking signal peptide. The profile of InsP6 degradation products produced by AC1-2 MINPP mirrors that of Acinetobacter sp. culture incubated with InsP6 (cf. Fig 1 and Rix et al [36], Fig 4).
Fig 4

Biochemical characterisation of AC1-2 MINPP.

A, The specificity of the enzyme towards different phosphate (P)—containing compounds assayed at 1mM. Significant differences between compound and InsP6 are indicated at P≤0.05, *; P≤0.01, **; P≤0.001, *** and P≤0.0001, ****. B, inhibition of activity by metal ions. Significant differences between metal ions and control are indicated at P≤0.05, *; P≤0.01, **; P≤0.001, *** and P≤0.0001, ****. C, pH-activity profile; D, thermostability. A-D, means and standard deviation of three measurements.

Biochemical characterisation of AC1-2 MINPP.

A, The specificity of the enzyme towards different phosphate (P)—containing compounds assayed at 1mM. Significant differences between compound and InsP6 are indicated at P≤0.05, *; P≤0.01, **; P≤0.001, *** and P≤0.0001, ****. B, inhibition of activity by metal ions. Significant differences between metal ions and control are indicated at P≤0.05, *; P≤0.01, **; P≤0.001, *** and P≤0.0001, ****. C, pH-activity profile; D, thermostability. A-D, means and standard deviation of three measurements. The ability of AC1-2 MINPP to use other commonly assayed substrates, adenosine triphosphate, glycerol 3-phosphate, glucose 6-phosphate, pyrophosphate, para-nitrophenyl phosphate and creatine phosphate was tested (Fig 4A). Within the HAPhy classification there are two subgroups, those that have a broad substrate specificity but a low specific activity and conversely, those that have a narrow substrate specificity and a high specific activity towards phytate [48]. AC1-2 MINPP is in the latter group, exhibiting narrow substrate specificity with relatively low activity towards other phosphorylated substrates such as para-nitrophenyl phosphate, 25.8%; and glycerol 3-phosphate 5.4%; in relation to InsP6. This specificity is in agreement with previous analyses of wheat, barley and avian MINPPs [12,52]. Prior to the post-genomic era, characterization of enzymes including phytases commonly tested the effect of metal ions and substrate analogues or residue-modifying reagents to probe reaction mechanisms. Such experiments have a contemporary relevance in consideration of biotechnological end use of phytases, in production systems and use in animals. We therefore tested potential metal ion inhibitors and substrate analogue at a concentration of 1 mM for effect on AC1-2 MINPP activity (Fig 4B). Metal ions are known to affect the activity of phytases, these may be due to the inability of the phytase to act upon metal ion-phytate complexes [53]. InsS6 is commonly used in crystallographic studies to aid in the identification of key active site residues [54]. Fe2+/3 showed the strongest inhibition of enzyme activity, 29 ± 6% by 1 mM followed by Cu2+> Mn+ > Co2+ > InS6 > Mg2+ > K+ > Zn2+ > nil addition and Ca2+. The pH profile of candidate feed enzymes is an important parameter. AC1-2 MINPP showed a broad pH-activity profile with three maxima at pH 3, 4.5–5 and 6 (Fig 4C). To determine the thermostability of AC1-2 MINPP, protein was incubated at temperatures in the range 4–70°C before the addition of InsP6 to assay activity (Fig 4D). Activity was abolished after incubation at 60°C and was reduced to 40 ± 3% to that of the control sample at 50°C.

Long term stability of AC1-2 MINPP

A long-term stability experiment was performed on AC1-MINPP. Aliquots of the protein preparation were stored at room temperature in a range of stabilising solutions or buffer only (control) and activity measured at intervals. AC1-2 MINPP showed a remarkable resilience to periodic fluctuations in room temperature during summer and winter months, with the protein retaining activity during two summer “heatwaves” where average room temperatures in the lab moved over 30°C (Fig 5A). We have no obvious explanation of the ‘dip’ in activity at 220 days and can only speculate that over the course of the observations differently calibrated pipettes might have been used.
Fig 5

Long-term stability of AC1-2 MINPP.

Stability was assessed in seven different stabilising solutions and a control (gel filtration buffer) during storage in ambient conditions. A, Isolation of AC1-2 MINPP through a two-step, Ni-affinity and size exclusion, purification. Aliquots of protein taken at different stages of the purification were subjected to SDS-PAGE on a 12% gel. Lanes labelled 1–9 are flanked, left, by molecular mass markers identified by mass (kDa). Lanes: 1 and 2, uninduced Rosetta ™ 2 (pLysS) cells; 3 and 4, 0.1 mM IPTG-induced cells; 5, crude lysate of concentrated, induced cells; 6, cell pellet; 7, clarified cell lysate (supernatant); 8, Amicon® Ultra-15 (10 kDa cut-off) -concentrated fraction, post Ni-affinity chromatography; 9, Amicon-concentrated fraction, post size exclusion chromatography. B, Enzyme activity of AC1-2 MINPP during prolonged storage at 4°C or ambient conditions (occasionally reaching 30–35°C). Protein was stored at a concentration of 4 μM in 50 mM Tris-HCl pH 7.5 300 mM NaCl (control) or in 25 mM Tris-HCl pH 7.5 150 mM NaCl with stabilising agent as indicated. Error bars show standard deviation of triplicate measurements. C. SDS-PAGE of AC1-2 MINPP stored for greater than three years at a concentration of 4 μM in 25 mM Tris-HCl pH 7.5 150 mM NaCl with stabilizing agents as indicated. Thereafter, aliquots of protein were subjected to SDS-PAGE on a 12% gel, Lanes 1–4, flanked on the left by molecular mass markers (kDa). Lanes, stabilising agents: 1, 30% w/v glycerol; 2, 30% w/v glycerol and 0.5 mg/ml BSA; 3, 30% w/v sucrose; 4, 30% w/v sucrose and 0.5 mg/ml BSA.

Long-term stability of AC1-2 MINPP.

Stability was assessed in seven different stabilising solutions and a control (gel filtration buffer) during storage in ambient conditions. A, Isolation of AC1-2 MINPP through a two-step, Ni-affinity and size exclusion, purification. Aliquots of protein taken at different stages of the purification were subjected to SDS-PAGE on a 12% gel. Lanes labelled 1–9 are flanked, left, by molecular mass markers identified by mass (kDa). Lanes: 1 and 2, uninduced Rosetta ™ 2 (pLysS) cells; 3 and 4, 0.1 mM IPTG-induced cells; 5, crude lysate of concentrated, induced cells; 6, cell pellet; 7, clarified cell lysate (supernatant); 8, Amicon® Ultra-15 (10 kDa cut-off) -concentrated fraction, post Ni-affinity chromatography; 9, Amicon-concentrated fraction, post size exclusion chromatography. B, Enzyme activity of AC1-2 MINPP during prolonged storage at 4°C or ambient conditions (occasionally reaching 30–35°C). Protein was stored at a concentration of 4 μM in 50 mM Tris-HCl pH 7.5 300 mM NaCl (control) or in 25 mM Tris-HCl pH 7.5 150 mM NaCl with stabilising agent as indicated. Error bars show standard deviation of triplicate measurements. C. SDS-PAGE of AC1-2 MINPP stored for greater than three years at a concentration of 4 μM in 25 mM Tris-HCl pH 7.5 150 mM NaCl with stabilizing agents as indicated. Thereafter, aliquots of protein were subjected to SDS-PAGE on a 12% gel, Lanes 1–4, flanked on the left by molecular mass markers (kDa). Lanes, stabilising agents: 1, 30% w/v glycerol; 2, 30% w/v glycerol and 0.5 mg/ml BSA; 3, 30% w/v sucrose; 4, 30% w/v sucrose and 0.5 mg/ml BSA. A similar experiment with a full-length, signal peptide-containing, and somewhat impure protein preparation showed low activity, around 13 U/mg at 37°C, that was maintained at room temperature and at 4°C (Supporting information). This protein yields products (Supporting information) that are identical to those obtained from AC1-2 MINPP (Fig 6). The experiments to determine enantiospecificity shown in Fig 6 were performed on glycerol/BSA-stabilized enzyme (lacking signal peptide) stored on the bench for > 3 years. Denaturing (SDS) polyacrylamide gel electrophoresis of the signal peptide-lacking protein, at point of preparation, is shown (Fig 5A). A similar analysis of the protein yielding results of Fig 6 is shown (Fig 5C). The greater than 3 year stability/activity of this enzyme is remarkable.
Fig 6

Enantiospecificity of AC1-2 MINPP attack on phytate.

HPLC of: A, products of incubation of a purified and desalted D-and/or L-Ins(1,2,3,4,5)P5 [InsP5 4/6-OH] fraction generated by AC1-2 MINPP with AtITPK1; B, a no-enzyme control for A; C, products of incubation of InsP6 with AtITPK1; D, a no-enzyme control for C. E, products of incubation of D-Ins(1,2,3,5,6)P5 (InsP5 [4-OH]) with AtITPK1. F, a no-enzyme control for E. G, Products of incubation of D-Ins(1,2,3,4,5)P5 (InsP5 [6-OH]) with AtITPK1. H, a no-enzyme control for G. Approximately, one third of sample equivalent (to A-E, and H) was injected for G. The units and scales of panels (A-H) are identical.

Enantiospecificity of AC1-2 MINPP attack on phytate.

HPLC of: A, products of incubation of a purified and desalted D-and/or L-Ins(1,2,3,4,5)P5 [InsP5 4/6-OH] fraction generated by AC1-2 MINPP with AtITPK1; B, a no-enzyme control for A; C, products of incubation of InsP6 with AtITPK1; D, a no-enzyme control for C. E, products of incubation of D-Ins(1,2,3,5,6)P5 (InsP5 [4-OH]) with AtITPK1. F, a no-enzyme control for E. G, Products of incubation of D-Ins(1,2,3,4,5)P5 (InsP5 [6-OH]) with AtITPK1. H, a no-enzyme control for G. Approximately, one third of sample equivalent (to A-E, and H) was injected for G. The units and scales of panels (A-H) are identical. AC1-2 MINPP was also assayed for analysis of kinetic parameters. The enzyme shows Michaelis-Menten kinetics and substrate inhibition, with a specific activity, V, of 228 U/mg, K of 0.65 mM and K 2.23 mM, respectively (Fig 7).
Fig 7

Kinetics parameters of AC1-2 MINPP activity against phytate.

Regulation of ac1-2 MINPP by substrate and product

In the absence of literature reports of the control of expression of bacterial MINPPs, we designed primer sets to determine the response of ac1-2 MINPP to growth condition. We chose rich and minimal media with or without the presence of InsP6, comparing ac1-2 MINPP expression to the ‘housekeeping’ gene RecA. cDNA from Acinetobacter sp. AC1-2 grown to exponential/late exponential was analysed for changes in expression. Due to the impurities commonly found in commercial bought InsP6, the concentration of inorganic phosphate therein was measured and equivalent concentration supplemented into minimal media [55]. ac1-2 MINPP expression was unaltered by InsP6, and associated phosphate, in LB. In minimal media, the inclusion of inorganic phosphate or InsP6 (containing inorganic phosphate impurity) reduced gene expression (p<0.05) by 2.6-fold and 7.5-fold, respectively (Fig 8).
Fig 8

Validation of the primer sets and quantification of expression of the ac1-2 MINPP by qPCR.

A, Log-linearity of amplification with primer sets; B, ΔCt value of the LB and LB + InsP6 environments; C, ΔCt of the MM, MM + Pi and MM + InsP6 environments; D, Fold change, calculated using the 2-ΔΔCt method.

Validation of the primer sets and quantification of expression of the ac1-2 MINPP by qPCR.

A, Log-linearity of amplification with primer sets; B, ΔCt value of the LB and LB + InsP6 environments; C, ΔCt of the MM, MM + Pi and MM + InsP6 environments; D, Fold change, calculated using the 2-ΔΔCt method.

Discussion

AC1-2 MINPP is one of the first phytases of this class isolated from the soil environment. MINPPs are related to branch 2 of the histidine acid superfamily, which contains the histidine acid phosphatases and phytases [48]. HAPhytases are characterised by their active site hepta-peptide sequence motif RHGxRxP and proton donor motif HD, and a large α/β domain and a α domain. The AC1-2 phytase contains a slightly different heptapeptide sequence motif, RHGSRGL, and has a tripeptide protein donor motif of HAE. Additionally, it contains several MINPP-specific motifs that are not found in HAPhys: PMAAN and LYNE are located on the β-sheets of the α/β domain; the methionine residue of PMAAN forms part of substrate specificity pocket A. The majority of MINPP studies describe a protein that is commonly found in eukaryotic organisms [12,52] but which has also been described in gut commensal bacteria [13,46]. It may be these unique properties which allow the soil derived MINPP to function over a wide range of pH, similar to the pH range in the digestive tract [56]. It is unusual that AC1-2 MINPP displays multiple maxima, with many bacterial phytases usually exhibiting either one or two maxima [57,58]. This phytase showed highest activity at pH 6 which deviates slightly from the optimal pH of histidine acid phosphatases which is typically within the pH range of 2.5–5.5, however this is not uncommon for many isolated phytases which have their pH optima in the range of 4.5–6. Indeed, it may be a feature of this relatively under-examined MINPP class. Phytases showing a diverse range of pH activity are preferable in animal feed applications as they must remain optimally active in the digestive tract [59]. AC1-2 MINPP shows continued activity for over 755 days in purified form at room temperature, in some cases, activity did not decrease. Bovine serum albumin as a co-protectant proved to be an excellent stabilising molecule maintaining higher enzyme activity in all treatments to which it was added. The inhibition of AC1-2 MINPP was tested using a range of metal ions and the substrate analogue InS6. Fe2+/3+ and Cu2+ reduced activity to < 50%, at 1mM, whereas Zn2+ ion was without strong effect. Typically, zinc is referenced as one of the most potent phytase inhibitors [52,60], however in this instance, activity was only reduced to 93%. Furthermore the substrate analogue IS6, also regarded as a potent inhibitor [61], reduced activity to only 72%. Activity was enhanced slightly, to 114% by calcium, a facet of character ordinarily associated with Beta-propeller phytases that have structural calcium ions [62]. Calcium is a critical component of feed matrices employed in poultry feed trials, with calcium, phytase and available phosphate carefully titrated to achieve optimum degradation of phytate in feed [63]. Laying hen diets typically include > 10% limestone [63]. AC1-2 MINPP also showed a relatively narrow substrate specificity, favouring InsP6 with minimal degradation of other glycerol 3-phosphate. AC1-2 MINPP shows substrate inhibition (K 2.2 mM). Substrate inhibition by phytate has been well documented [56]. The fungi A. ficuum and bacteria C. braakii YH-15 phytases showed inhibition at phytate concentrations above 1.2 mM and 1.5 mM respectively [64,65]. The K (0.65 mM) of AC1-2 MINPP is typical of the values reported (0.15–1.37 mM) for a range of anonymous commercial phytases [66]. The V value of 228 U/mg, while lower than that (1123 U/mg) of the codon-optimized histidine acid (HD) phytase AppaAs-OP (optimized for expression in Komagataella phaffii [66] is greater than that [23–196 U/mg) of a range of fungal phytases [59,67] with which AC1-2 MINPP and other bacterial MINPPs [11] show greater structural similarity, but again less than that (∼2,000 U/mg) of Peniophora lycii [68]. The extreme stability of this enzyme, greater than 3 years on the bench, show that the MINPP scaffold is a very good starting point for engineering this class of enzyme, or for searches for related enzymes. The commercial choice of enzyme rests on much more than simple specific activity. Choice is tempered by expression host, cost effective processing and opportunity for engineering thermostability and protease resistance. Indeed, current commercial enzymes have been engineered to increase thermostability. In the case of E coli AppA-derivatives Tm has been increased by more than 12 degrees [69]. In bacteria, phytase is the product of an inducible gene that may be subject to complex regulation [70,71]. A general feature commonly observed in microbial phytase producers is the regulatory inhibition of phytase production by inorganic phosphate levels [71]. This may have an effect on the RT-qPCR results displayed (Fig 8) as many of the commercial phytates available contain high levels of inorganic phosphate or other inositol phosphates [44,72]. Nevertheless, our data show dual aspect to regulation of AC1-2 MINPP phytase activity, by inorganic phosphate and phytate. Moreover, phytase activity is regulated at both transcriptional and post-translational, levels: AC1-2 down regulates transcription of the MINPP gene at levels of substrate approaching K. In other species, phytase production has been shown to be sensitive to growth phase, being suppressed during the exponential phase in E. coli and Raoultella terrigena, with resumption of expression upon entering stationary phase [73]. There is still much to be understood about the induction and repression of phytase genes, the expression of which does not appear to be uniformly controlled amongst bacteria [71].

Conclusions

AC1-2 MINPP, isolated from soil, is a MINPP phytase that displays 5-phytase and D6-phytase activity among other activities. It shows extraordinary long-term stability. The enzyme exhibits many desirable traits that suit its development for use in the animal feed industry. (XLSX) Click here for additional data file. (PDF) Click here for additional data file. 24 May 2022
PONE-D-22-06931
Characterisation of a Soil MINPP Phytase with Remarkable Long-Term Stability and Activity from Acinetobacter sp.
PLOS ONE Dear Dr. Brearley, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
 
In your revised manuscript please address as fully as possible the highly critical and constructive comments of Reviewer 1. Please submit your revised manuscript by Jul 08 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Israel Silman Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: “GDR was funded by the Natural Environment Research Council (NERC) PhD studentships (NERC Doctoral Training Programme grant NE/L002582/1) with support from AB Vista.” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “GDR Natural Environment Research Council (NERC) PhD studentships (NERC Doctoral Training Programme grant NE/L002582/1) https://nerc.ukri.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Phytases are routinely added to farm animal feed to improve phosphate bioavailability from animal feed, and to reduce environmental phosphate contamination. The authors note that research is ongoing to identify and/or engineer phytases with improved catalytic activity, pH activity profile, heat stability, and to lower costs. Into this mix they now add the characteristics of a AC1-2 MINPP, a MINPP-like phytase form a soil Acinetobactor sp, that was recently published by the authors’ laboratory (ref 36). However, there are a number of problems with this work. 1. Figure 1 show the phylogenetic relationship of AC1-2 MINPP to other phytases. This seems unnecessary, because a conceptually similar figure is provided in the author’s previous publication (ref 36). Yes, the current one analyzes more proteins, but no new conclusions are evident. 2. In the absence of real structure, it is understandable that the authors provide a proposed structure obtained by homology modeling based on the BlMINPP template. Lines 221 to 269 discusses this model, leading to predictions about catalytic contributions of a so-called U-loop, and predictions about residue determinants of positional specificity towards individual phosphate groups. But it is ‘only’ a model (‘proposed’ structural features. . .would have made for a more appropriate header for Figure 4). None of the shortcomings of this modeling have been acknowledged by the authors. In particular, the structure of flexible loops (such as MINPP’s U-loop) is particularly prone to predictive inaccuracy. Moreover, the authors do not model into the active site the natural substrate (inositol hexakisphosphate; IP6), but instead favor a non-metabolized inositol hexasulfate (IS6) substrate analogue (based on a previous paper: ref 11). Furthermore, in their homology modeling template, IS6 exhibits conformational disorder (that is, it binds in multiple orientations). Surely it must be questioned how reliable are these efforts to explain positional specificity using a mobile substrate analogue. To further subtract confidence from the model, the template displays a conformationally active (induced fit) reaction cycle – how reliable, then, is a static model? Another factor that impinges on the reliability of these predictions is not knowing whether it is the 4- or 6-phosphate that is initially hydrolyzed, and yet the authors are willing to attribute six polar contacts between the protein and this (incompletely determined) scissile phosphate. 3. MINPP protein was purified by a two step procedure – a Histrap column followed by gel filtration. Considering the relative simplicity of this protocol, the authors should have provided a silver-stained gel so that purity – and hence the accuracy of the specific activity data - could then be properly assessed. 4. Line 212. Is it really safe to “assume” that the axial 2-phosphate of any inositol phosphate cannot be hydrolyzed by this enzyme, just because it is not removed from IP6? (lines 119-120). Or maybe the 2-phosphate IS removed and the I(1,3,4,5,6)P5 product is so rapidly hydrolyzed it does not accumulate? 5. AC1-2 MINPP is 26% as active against para-nitrophenyl phosphate (PNP) compared to IP6 (does this really qualify as being ‘low’ activity (line 282)? This substrate preference is said to be in agreement with a previous study of avian and plant MINPPs (ref 12,49). I checked and the cited references give 45-48% for plant MINPPS (PNP vs IP6) and only 7% for avian MINPP. I’m not sure how much either result is ‘in agreement’ with the current analysis. That being said, the substrate preferences will also be influenced by the PNP concentration used and its Km value; this important information is not provided by the authors. 6. line 295 and lines 340-341. A little too much is made of the ‘third pH maxima’ of AC1-2 MINPP (Fig 5C), which almost qualifies as an inflection point, rather than a peak, since the activities at pH 3 and 3.5 are barely different. Also, Fig. 5A does not have error bars. 7. Fig. 6. This figure shows enzyme activity over an 800-day time period when the enzyme was exposed to ambient lab temperature. The apparent fall in activity around day 200 with subsequent recovery is a strange observation that gets no mention. In any case, the scientific value of this experiment is questionable since it would be impossible to reproduce. Contemporaneous monitoring of maximum and minimum ambient temperatures, plus gel analysis to look for possible degradation, and a comparison with other MINPP/phytase enzymes, could together have elevated the value of this experiment. In any case, the authors indicate in the Fig 6 legend that this time course included periods when heatwaves caused ambient temperatures to reach 30 to 35 degrees for several days. The conclusion that during this time MINPP exhibits ‘remarkable long-term stability’ (this phrase is in the title) is not consistent with the data in Fig. 5d, which shows a mere 10 min at 37 degrees causes activity to fall by about 60%. 8. Lines 366-370. Here, the authors make clear that the activity of AC1-2 MINPP (228 U/mg) is below the ‘record highs’ for this enzyme class (1123-2000 U/mg) and only slightly above the more general range of values of other phytases reported in the literature (23-196 U/mg). In that sense, AC1-2 MINPP is not especially notable as a new starting point for engineering higher phytase activity for addition to farm animal feed. Reviewer #2: The article by Rix and co-workers represents a solid and important piece of work. The article contributes new insights and significantly increases understanding of the potential of phytases. In this case, it concerns MINPP phytase from soil, a phytase n with some very interesting properties. The necessary experiments have been performed and the manuscript is well structured and well written. I have only a simple concern with the present manuscript and it deals with the lack of statistical analysis in Figures 5A and 5B. A statical analysis will strengthen the manuscript considerably. And, it should be a simple thing to add. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 30 Jun 2022 When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. We have added a file to the supplementary information Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: “GDR was funded by the Natural Environment Research Council (NERC) PhD studentships (NERC Doctoral Training Programme grant NE/L002582/1) with support from AB Vista.” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. We have removed the Acknowledgements Section and the following paragraph describing contributions, as both sets of information are provided in the online submission form. The Funding Statement includes details accompanying a new author who conducted new experiments designed to answer the criticisms of Reviewer 1. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: GDR was funded by a Natural Environment Research Council (NERC) PhD studentship (NERC Doctoral Training Programme grant NE/L002582/1) with support from AB Vista HW was funded by a Natural Environment Research Council grant (NE/W000350/1) https://nerc.ukri.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Yes ________________________________________ 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: No ________________________________________ 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ________________________________________ 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ________________________________________ 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Phytases are routinely added to farm animal feed to improve phosphate bioavailability from animal feed, and to reduce environmental phosphate contamination. The authors note that research is ongoing to identify and/or engineer phytases with improved catalytic activity, pH activity profile, heat stability, and to lower costs. Into this mix they now add the characteristics of a AC1-2 MINPP, a MINPP-like phytase form a soil Acinetobactor sp, that was recently published by the authors’ laboratory (ref 36). However, there are a number of problems with this work. We thank our reviewers for their input. In our address to their considered criticism, we think the manuscript is much improved. The extra experiments that we describe demand the addition of a new author (Hayley Whitfield) and funding details. 1. Figure 1 show the phylogenetic relationship of AC1-2 MINPP to other phytases. This seems unnecessary, because a conceptually similar figure is provided in the author’s previous publication (ref 36). Yes, the current one analyzes more proteins, but no new conclusions are evident. We have retained the figure, but have moved it to Supplementary Information (Figure S1). The extra information may be useful to some readers. 2. In the absence of real structure, it is understandable that the authors provide a proposed structure obtained by homology modeling based on the BlMINPP template. Lines 221 to 269 discusses this model, leading to predictions about catalytic contributions of a so-called U-loop, and predictions about residue determinants of positional specificity towards individual phosphate groups. We thank the reviewer for their thoughtful comments on our modelling procedure and positive criticisms of our interpretation of results. These have prompted further experiments, which we think are quite illuminating, and some reappraisal of this manuscript’s findings. But it is ‘only’ a model (‘proposed’ structural features. . .would have made for a more appropriate header for Figure 4). New Figure 4C title: Residues predicted to contribute to the specificity pockets of AC1-2 and other selected histidine phytases. None of the shortcomings of this modeling have been acknowledged by the authors. In particular, the structure of flexible loops (such as MINPP’s U-loop) is particularly prone to predictive inaccuracy. We accept this criticism and have diluted our discussion accordingly. We have also included the following statement. “However, it is relevant to note that the nature of the homology modelling process, particularly with respect to the prediction of the conformation of large polypeptide loops, leaves room for considerable uncertainty in the conformation of the U-loop in our model of AC1-2.” Moreover, the authors do not model into the active site the natural substrate (inositol hexakisphosphate; IP6), but instead favor a non-metabolized inositol hexasulfate (IS6) substrate analogue (based on a previous paper: ref 11). Our modelling was informed by the knowledge that myo-inositol hexakisphosphate is the substrate and that myo-inositol hexakissulfate (InsS6) is commonly reported to act as a competitive inhibitor of phytases and in crystal structures is assumed to mimic the substrate by adopting a pseudo-productive binding mode (Chu et al., 2004; Zeng et al., 2011; Stentz et al., 2014; Acquistapace et al., 2020). As such, we took the minimally invasive step of simply transferring the coordinates of the InsS6 ligand from the homology modelling template structure (PDB 6RXE) to our homology model and replacing the sulfate groups with phosphates. We have further modified the text to reflect this. Furthermore, in their homology modeling template, IS6 exhibits conformational disorder (that is, it binds in multiple orientations). Surely it must be questioned how reliable are these efforts to explain positional specificity using a mobile substrate analogue. MINPPs, unlike the mineralizing histidine acid phytases, are relatively undiscriminating in their selection of the first phosphate to release from phytate. In our original work, we presumed AC1-2 to be a preferential 6-phytase as no mineralizing enzymes of the histidine phosphatase family have been shown to possess 4- positional specificity. Consequently, we transferred only that conformation of the inhibitor with the 6-sulfate bound in the enzyme A specificity pocket to generate a model for holo-AC1-2. Prompted by this reviewer’s comments we reconsidered the structure of PDB 6RXE and discovered that binding of the 6- or 4-sulfate groups in the A-pocket of BlMINPP has no influence of the residue contacts in any of the specificity pockets except D and E. This is because the sulfate groups of the two binding poses are essentially superimposable in pockets A, B, C and F. In fact, in PDB 6RXE, docking the 4-sulfate group into the A-pocket instead of the 6-sulfate leads to the loss of only two contacts in each of pockets D and E. If InsS6 can be taken to be a true pseudosubstrate inhibitor, then these small differences may form the basis for discrimination between preferential 4- and 6-phytase activity. However, in our modelling we are only attempting to distinguish those interactions in specificity pockets which differ between 4/6-, 5- and 3-phytases and, as such, this difference is unimportant. We have modified the text to explain these differences. To further subtract confidence from the model, the template displays a conformationally active (induced fit) reaction cycle – how reliable, then, is a static model? The fact that the enzyme is predicted to undergo α-domain rotation on substrate binding due to the presence of a U-loop is essentially immaterial to the prediction of the interactions with substrate in the specificity pockets in the productive substrate-bound state. The reliability of our prediction depends only on those interactions involving U-loop residues for which we acknowledge a high degree of uncertainty exists due to the inaccuracies of the modelling process. Another factor that impinges on the reliability of these predictions is not knowing whether it is the 4- or 6-phosphate that is initially hydrolyzed, and yet the authors are willing to attribute six polar contacts between the protein and this (incompletely determined) scissile phosphate. PDB 6RXE shows InsS6 to exhibit static disorder in its complex with BlMINPP with both 4- and 6-sulfates bound in the catalytic A-pocket in separate poses. This observation is consistent with the evidence from HPLC that the enzyme displays 4- and/or 6-phytase positional specificity. The 4- and 6-sulfate groups of the two poses are superimposable and indistinguishable. If we presume that InsS6 is a true substrate mimic and adopts a pseudo-productive binding mode, then when bound in the A-specificity pocket the interactions of both the 4- and 6-phosphate groups of phytate with active site residues must also be indistinguishable. Hence, both will be assigned six identical polar contacts. Nevertheless, we describe additional experiments (Figure 2 with associated text) which employ an enzyme that distinguishes between D-Ins(1,2,3,4,5)P5 and D-Ins(1,2,3,5,6)P5 to show that the InsP5 products of AC1-2 MINPP-catalyzed dephosphorylation of InsP6 include D-Ins(1,2,3,4,5)P5. Consequently, our modelling as a 6-phytase is valid. We do not discount additional 4-phytase activity. 3. MINPP protein was purified by a two step procedure – a Histrap column followed by gel filtration. Considering the relative simplicity of this protocol, the authors should have provided a silver-stained gel so that purity – and hence the accuracy of the specific activity data - could then be properly assessed. We have now provided gel images in Figure 6 and Fig. S4, albeit not silver stained. 4. Line 212. Is it really safe to “assume” that the axial 2-phosphate of any inositol phosphate cannot be hydrolyzed by this enzyme, just because it is not removed from IP6? (lines 119-120). Or maybe the 2-phosphate IS removed and the I(1,3,4,5,6)P5 product is so rapidly hydrolyzed it does not accumulate? We take the reviewer’s point, but find it harder to propose that the absence of a particular InsP5 product can be taken as evidence of its generation. We point out that we should perhaps have stated that there is no precedent for 2-phytases in the MINPP or Histidine Acid Phytase literature. We also note that within phytase classes testing of (lack of) removal of 2-P was explicitly tested for BtMINPP (Stentz et al. 2014 [13] cited in the text). We now make these arguments in the narrative. We also describe new experiments designed to identify InsP4 products, discounting Ins(1,3,4,5)P4 and Ins (1,4,5,6)P4 or their enantiomers as products of AC1-2 MINPP action on InsP6 (Figure S2) It remains the case that the most parsimonious explanation of the absence of Ins(1,3,4,5,6)P5 among products, is that the enzyme does not remove the 2-phosphate of InsP6. 5. AC1-2 MINPP is 26% as active against para-nitrophenyl phosphate (PNP) compared to IP6 (does this really qualify as being ‘low’ activity (line 282)? This substrate preference is said to be in agreement with a previous study of avian and plant MINPPs (ref 12,49). I checked and the cited references give 45-48% for plant MINPPS (PNP vs IP6) and only 7% for avian MINPP. I’m not sure how much either result is ‘in agreement’ with the current analysis. That being said, the substrate preferences will also be influenced by the PNP concentration used and its Km value; this important information is not provided by the authors. We have modified the description of the results presented in Figure 5 and have provided details of the substrate concentration. We do not feel it necessary in describing a phytase to enquire of the Km for PNP, not least since the enzyme was isolated in a screen for phytase degrading isolates. 6. line 295 and lines 340-341. A little too much is made of the ‘third pH maxima’ of AC1-2 MINPP (Fig 5C), which almost qualifies as an inflection point, rather than a peak, since the activities at pH 3 and 3.5 are barely different. Also, Fig. 5A does not have error bars. We have modified the text (addition of reference to the literature (11) and citations therein) to describe contemporaneous description of similar pH profiles in other MINPPs. We have added the error bars and statistical test to original 5A (Figure 5A). 7. Fig. 6. This figure shows enzyme activity over an 800-day time period when the enzyme was exposed to ambient lab temperature. The apparent fall in activity around day 200 with subsequent recovery is a strange observation that gets no mention. We have added comment to the narrative. In any case, the scientific value of this experiment is questionable since it would be impossible to reproduce. Contemporaneous monitoring of maximum and minimum ambient temperatures, plus gel analysis to look for possible degradation, and a comparison with other MINPP/phytase enzymes, could together have elevated the value of this experiment. We wholly disagree, an enzyme retaining activity for greater than 2 years without refrigeration is remarkable. Following the reviewer's suggestion, we have added a poly acrylamide gel of our 3 year-old ‘bench-stored’ enzyme. For this we undertook analysis of protein stored in sucrose, sucrose and BSA, glycerol and glycerol and BSA. The results (Figure S4) show that AC1-2 MINPP has not been degraded during storage for 3 y on the bench. In any case, the authors indicate in the Fig 6 legend that this time course included periods when heatwaves caused ambient temperatures to reach 30 to 35 degrees for several days. The conclusion that during this time MINPP exhibits ‘remarkable long-term stability’ (this phrase is in the title) is not consistent with the data in Fig. 5d, which shows a mere 10 min at 37 degrees causes activity to fall by about 60%. We have undertaken extra experiments with enzyme that has been on the bench for > 3y. These experiments are described in the text and are shown in a new figure (Figure 2). They make it clear that the enzyme has extraordinary stability. We retain the data of original Figure 5D as Figure 6. 8. Lines 366-370. Here, the authors make clear that the activity of AC1-2 MINPP (228 U/mg) is below the ‘record highs’ for this enzyme class (1123-2000 U/mg) and only slightly above the more general range of values of other phytases reported in the literature (23-196 U/mg). In that sense, AC1-2 MINPP is not especially notable as a new starting point for engineering higher phytase activity for addition to farm animal feed. We disagree, the extreme stability of this enzyme makes it clear that the scaffold could be a good starting point for engineering this class of enzyme, or for searches for related enzymes. We make the point that the commercial position rests on much more than simple specific activity and that current commercial enzymes have been engineered to increase thermostability (in the case of E coli AppA-derivatives, Tm has been increased by more than 12 degrees, probably closer to 20 degrees since first description). We have added this argument to the text with a contemporary reference (72). Two new references have been added for the discussion of modelling Chu, H. M. et al. (2004) ‘Structures of Selenomonas ruminantium phytase in complex with persulfated phytate: DSP phytase fold and mechanism for sequential substrate hydrolysis’, Structure. Structure, 12(11), pp. 2015–2024. doi: 10.1016/j.str.2004.08.010. Zeng, Y. F. et al. (2011) ‘Crystal structures of Bacillus alkaline phytase in complex with divalent metal ions and inositol hexasulfate’, Journal of Molecular Biology. Academic Press, 409(2), pp. 214–224. doi: 10.1016/j.jmb.2011.03.063. Reviewer #2: The article by Rix and co-workers represents a solid and important piece of work. The article contributes new insights and significantly increases understanding of the potential of phytases. In this case, it concerns MINPP phytase from soil, a phytase with some very interesting properties. The necessary experiments have been performed and the manuscript is well structured and well written. I have only a simple concern with the present manuscript and it deals with the lack of statistical analysis in Figures 5A and 5B. A statical analysis will strengthen the manuscript considerably. And, it should be a simple thing to add. The error bars and statistical analysis has been added to the figure (Figure 5). 12 Jul 2022 Characterisation of a Soil MINPP Phytase with Remarkable Long-Term Stability and Activity from Acinetobacter sp. PONE-D-22-06931R1 Dear Dr. Brearley, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Israel Silman Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I have reviewed the revised ms and the supporting letter from the authors. The authors have carefully addressed my concerns and the ms should now be accepted. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** 19 Aug 2022 PONE-D-22-06931R1 Characterisation of a Soil MINPP Phytase with Remarkable Long-Term Stability and Activity from Acinetobacter sp. Dear Dr. Brearley: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Israel Silman Academic Editor PLOS ONE
  54 in total

Review 1.  Monitoring complex bacterial communities using culture-independent molecular techniques: application to soil environment.

Authors:  L Ranjard; F Poly; S Nazaret
Journal:  Res Microbiol       Date:  2000-04       Impact factor: 3.992

2.  Improving specific activity and thermostability of Escherichia coli phytase by structure-based rational design.

Authors:  Tzu-Hui Wu; Chun-Chi Chen; Ya-Shan Cheng; Tzu-Ping Ko; Cheng-Yen Lin; Hui-Lin Lai; Ting-Yung Huang; Je-Ruei Liu; Rey-Ting Guo
Journal:  J Biotechnol       Date:  2014-02-08       Impact factor: 3.307

3.  The phytases. II. Properties of phytase fractions F 1 and F 2 from wheat bran and the myoinositol phosphates produced by fraction F 2 .

Authors:  P E Lim; M E Tate
Journal:  Biochim Biophys Acta       Date:  1973-04-12

4.  Production and characterization of thermostable alkaline phytase from Bacillus laevolacticus isolated from rhizosphere soil.

Authors:  H K Gulati; B S Chadha; H S Saini
Journal:  J Ind Microbiol Biotechnol       Date:  2006-09-12       Impact factor: 3.346

5.  Crystal structures of Bacillus alkaline phytase in complex with divalent metal ions and inositol hexasulfate.

Authors:  Yi-Fang Zeng; Tzu-Ping Ko; Hui-Lin Lai; Ya-Shan Cheng; Tzu-Hui Wu; Yanhe Ma; Chun-Chi Chen; Chii-Shen Yang; Kuo-Joan Cheng; Chun-Hsiang Huang; Rey-Ting Guo; Je-Ruei Liu
Journal:  J Mol Biol       Date:  2011-04-02       Impact factor: 5.469

6.  Lily pollen alkaline phytase is a histidine phosphatase similar to mammalian multiple inositol polyphosphate phosphatase (MINPP).

Authors:  Bakul Dhagat Mehta; Sonali P Jog; Steven C Johnson; Pushpalatha P N Murthy
Journal:  Phytochemistry       Date:  2006-07-24       Impact factor: 4.072

7.  Crystallographic snapshots of Aspergillus fumigatus phytase, revealing its enzymatic dynamics.

Authors:  Qun Liu; Qingqiu Huang; Xin Gen Lei; Quan Hao
Journal:  Structure       Date:  2004-09       Impact factor: 5.006

8.  SWISS-MODEL: homology modelling of protein structures and complexes.

Authors:  Andrew Waterhouse; Martino Bertoni; Stefan Bienert; Gabriel Studer; Gerardo Tauriello; Rafal Gumienny; Florian T Heer; Tjaart A P de Beer; Christine Rempfer; Lorenza Bordoli; Rosalba Lepore; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

9.  Functional Metagenomics Reveals a New Catalytic Domain, the Metallo-β-Lactamase Superfamily Domain, Associated with Phytase Activity.

Authors:  Genis Andrés Castillo Villamizar; Katrina Funkner; Heiko Nacke; Karolin Foerster; Rolf Daniel
Journal:  mSphere       Date:  2019-06-19       Impact factor: 4.389

10.  Interactive Tree Of Life (iTOL) v4: recent updates and new developments.

Authors:  Ivica Letunic; Peer Bork
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.